Beyond Stress Granules: G3BP1 and G3BP2 Redundantly Suppress SARS-CoV-2 Infection
The global pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has posed unprecedented challenges to public health and economic stability. Central to SARS-CoV-2 pathogenesis is its ability to evade the host immune response by hijacking host pathways via the interaction between viral and host proteins. We identified Ras-GTPase-activating protein SH3 domain-binding protein 1/2 (G3BP1/G3BP2) as a critical host factor that interacts with the viral nucleocapsid (N) protein, emerging from a comparative analysis of proteomic data from multiple studies. We revisited the underlying molecular mechanisms by confirming the residues required for the interaction between G3BP1/G3BP2 and SARS-CoV-2 N protein and showed that this interaction disrupts stress granule formation. Intriguingly, we observed that the ablation of both G3BP1 and G3BP2 enhanced SARS-CoV-2 replication. Our data collectively supports the notion that G3BP1 and G3BP2 play a critical role in modulating the host-virus interface during SARS-CoV-2 infection, and that their multifaceted function in cellular defense extends beyond the stress granule pathway.
Authors
- Quanqing Zhang (ORCID: https://orcid.org/0000-0002-6400-8613)
- Duo Xu (ORCID: https://orcid.org/0000-0003-2554-3602)
- Jikui Song (ORCID: https://orcid.org/0000-0002-4958-1032)
- Chen Ye (ORCID: https://orcid.org/0000-0003-2952-6586)
- Christine Light
- Luis Martínez‐Sobrido (ORCID: https://orcid.org/0000-0001-7084-0804)
- Mahamaya Biswal (ORCID: https://orcid.org/0000-0002-8995-2635)
- Rong Hai (ORCID: https://orcid.org/0000-0002-0577-4676)
- Yijie Wu
Institutions
- University of California, Riverside (US)
- Texas Biomedical Research Institute (US)
Publication Details
- Journal
- Viruses
- Published
- 2025-06-27
- DOI
- https://doi.org/10.3390/v17070912
- Citations
- 5
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 6.98
Funders
- National Institute of Allergy and Infectious Diseases